8-K: Knowles Corporation Appoints Laura Angelini to Board of Directors

Knowles Corporation has appointed Laura Angelini, a seasoned executive with 30 years of experience in the medical device and healthcare industry, to its Board of Directors.

Summary

• Knowles Corporation has elected Laura Angelini as a new independent director to its Board of Directors, effective December 6, 2024.
• Ms. Angelini brings 30 years of experience in the medical device and healthcare industry, having held leadership positions at Baxter International and Johnson & Johnson.
• She will also serve on the Compensation Committee of the Board.
• Ms. Angelini's appointment is part of Knowles' strategic transformation to focus on higher value markets and products.
• She will receive standard compensation for non-employee directors, including an annual retainer and restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a positive development with the appointment of an experienced director, but it is a routine corporate governance event rather than a major financial announcement.

Positives

• The appointment of Laura Angelini brings significant experience in the medical device and healthcare industry to the Knowles board.
• Her background aligns with Knowles' strategic focus on higher value markets and products.
• Ms. Angelini's experience in global strategic marketing and executive leadership is expected to benefit the company.
• Her appointment to the Compensation Committee adds valuable expertise to this key board function.

Future Outlook

Knowles aims to enhance shareholder value by focusing on higher value markets and products, leveraging Ms. Angelini's expertise.

Management Comments

• Don Macleod, chairman of the board of Knowles, stated that Ms. Angelini's experience will benefit Knowles as they continue the company's strategic transformation.
• He also noted her insights into the healthcare and medical markets will be valuable.

Industry Context

The appointment of a director with extensive medical device experience aligns with Knowles' strategy to expand into high-value markets such as medtech, indicating a focus on diversification and growth in this sector.

Comparison to Industry Standards

• The compensation structure for non-employee directors at Knowles, including cash retainers and stock grants, is consistent with industry standards for publicly traded companies.
• The appointment of an independent director with significant experience in a relevant industry is a common practice to enhance board expertise and corporate governance.
• Companies like Medtronic and Abbott also have board members with similar backgrounds in medical devices and healthcare.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment positively due to Ms. Angelini's experience and potential contribution to the company's strategic goals.
• The appointment is not expected to have a direct impact on employees, customers, or suppliers.

Next Steps

• Ms. Angelini will serve on the Board until the next annual meeting of shareholders.
• She will participate in the Compensation Committee meetings.

Key Dates

Keywords

Board of Directors, Laura Angelini, Medical Device, Healthcare, Corporate Governance, Compensation Committee, Director Appointment, Knowles Corporation